Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes
ShareXFacebook

(MedPage Today) -- NEW ORLEANS -- Treatment with investigational elecoglipron led to weight loss in people with obesity and improved glucose control in those with type 2 diabetes, a pair of global phase II randomized trials showed. In the dose...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement